Boris Calmels

6PUBLICATIONS
28CO-AUTHORS
Haematological tumoursBioprocessing, bioproduction and bioproductsHaematologyTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 27, 2026
Fludarabine, cyclophosphamide and 2 Gy TBI with PT-Cy as a single platform for haplo and unrelated donor allo-SCT in older AML or MDS patients.

|Dec 11, 2025
Securing raw materials, reagents, and consumable supplies in the academic bioproduction UNITC network: because the chain is only as strong as its weakest link.

Ugo Chartral, Jeanne Galaine, Camille Giverne

|Mar 15, 2024
Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease.

Sabine Fürst, Emmanuelle Bernit, Faezeh Legrand

|Nov 04, 2023
Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome.

Samia Harbi, Louison Brac de la Perriere, Benjamin Bouchacourt

|Aug 09, 2023
GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation.

François Dachy, Sabine Furst, Boris Calmels

|Apr 13, 2021
Related versus unrelated allogeneic HPC graft cryopreservation: a single-center experience in the context of the global COVID-19 pandemic.

B Mfarrej, C Lemarié, A Granata

Pageof 1

Frequent Collaborators

5 joint publications

Didier Blaise

5 joint publications

Christian Chabannon

4 joint publications

Benjamin Bouchacourt

4 joint publications

Raynier Devillier